KERYX BIOPHARMACEUTICALS INC·4

Mar 22, 5:31 PM ET

Madison Greg 4

4 · KERYX BIOPHARMACEUTICALS INC · Filed Mar 22, 2018

Insider Transaction Report

Form 4
Period: 2018-03-20
Madison Greg
See Remarks
Transactions
  • Award

    Common Stock

    2018-03-20+152,500566,586 total
  • Award

    Stock Options (right to buy)

    2018-03-20+305,000305,000 total
    Exercise: $4.16From: 2019-03-20Exp: 2028-03-20Common Stock (305,000 underlying)
Footnotes (3)
  • [F1]The 152,500 shares are restricted common stock, with one-third of the 152,500 shares vesting on March 20, 2019 and one-twelfth vesting on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.
  • [F2]Includes 303,747 shares of restricted stock.
  • [F3]The stock options vest according to the following schedule: one-third of the 305,000 options will vest on March 20, 2019 and one-twelfth will vest on each of June 20, 2019, September 20, 2019, December 20, 2019, March 20, 2020, June 20, 2020, September 20, 2020, December 20, 2020 and March 20, 2021.

Documents

2 files
  • 4
    wf-form4_152175428909317.xmlPrimary

    FORM 4

  • EX-24

    GREG MADISON POWER OF ATTORNEY - FEB 2018